NLRC4
protein-codingNLR family CARD domain containing 4, the group of NLR family|Caspase recruitment domain containing
Gene summary
This gene encodes a member of the caspase recruitment domain-containing NLR family. Family members play essential roles in innate immune response to a wide range of pathogenic organisms, tissue damage and other cellular stresses. Mutations in this gene result in autoinflammation with infantile enterocolitis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2014]
- CARD12
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~41.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0014472
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0014472
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0014498
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0014472
Submitter: Illumina
The NLRC4 gene is located on chromosome 2 at 2p22.3 and encodes the NLR family CARD domain containing 4 protein. As a key component of the NLRC4 inflammasome, this protein plays an important role in innate immune responses. NLRC4 oligomerization triggers inflammasome assembly and activation, which leads to the activation of caspase-1, production of cytokines such as IL-1β and IL18, and inflammatory cell death, or pyroptosis. NLRC4 was first reported in relation to autosomal dominant NCRL4 related autoinflammatory syndrome in 2014 (25217960: Romberg et al. 201; 25217959: Canna et al. 2014). Evidence supporting this gene-disease relationship includes case-level data, segregation data and experimental data. At least five missense variants have been identified in a heterozygous state in six affected cases (25217960: Romberg et al. 2014; 25217959: Canna et al. 2014; 25385754: Kitamura et al. 2014; 27203668: Volker-Touw et al. 2017; 29778503: Moghaddas et al. 2018). In four affected individuals NLRC4 variants occurred de novo, in two families the NLRC4 variant segregated with disease. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. Data examining the impact of pathogenic variants on NLRC4 function, provide evidence for a gain of function mechanism of disease (25217960: Romberg et al. 2014; 25217959: Canna et al. 2014; 25385754: Kitamura et al. 2014). The gene-disease relationship is also supported by a knock-in mouse model which recapitulates the human phenotype (25385754: Kitamura et al. 2014). In summary, NLRC4 is definitively associated with autosomal dominant NCRL4 related autoinflammatory syndrome. Lumping and splitting considerations: OMIM 616115: Familial cold autoinflammatory syndrome 4; OMIM 616050:Autoinflammation with infantile enterocolitis. According to the criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism or inheritance pattern and the above disorders were ‘lumped’ into the term NLRC4-associated autoinflammatory disease. Duncan and Canna (2018; PMID 29247997) describe the spectrum of NLRC4-associated autoinflammatory diseases and highlight that not all patients with NLRC4 inflammasomopathy develop macrophage activation syndrome (MAS) or enterocolitis. All variants described to date in association with this spectrum of disorders have been heterozygous gain-of-function variants, indicating no difference in inheritance pattern or disease mechanism. Although a small number of patients have been described, the possibility of genotype/phenotype correlation based on variant location has been proposed.
Inheritance Pattern: AD
Disease ID:MONDO:0014472
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious
Intervention: Allergy/Immunology/Infectious
Rationale: In Autoinflammation with infantile enterocolitis, individuals present with recurrent autoinflammatory manifestations in infancy, and treatment with IL1R antagonists has been described as beneficial (decreased frequency of flares, corticosteroid requirements, and clinical and lab severity); In Familial cold autoinflammatory syndrome 4, manifestations frequently resolve without treatments, though analgesics may be helpful related to joint pain
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to NLRC4 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001199138.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 10 | 202 | 4 | 216 | ||
| missense | 6 | 7 | 489 | 40 | 1 | 543 |
| nonsense | 1 | 16 | 3 | 20 | ||
| start loss | 0 | |||||
| frameshift | 1 | 25 | 12 | 38 | ||
| splice donor/acceptor (+/-2bp) | 7 | 1 | 8 | |||
| Total | 6 | 9 | 547 | 258 | 5 | 825 |
Highest pathogenic variant AF is 0.0000020521604
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001186067.1 | 8 | MANE Select | |
| Ensembl | ENSP00000385428.1 | 8 | MANE Select | |
| RefSeq | NP_001186068.1 | 8 | Standard | |
| RefSeq | NP_001289433.1 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Salmonella infection - Homo sapiens (human)
- Legionellosis - Homo sapiens (human)
- NOD-like receptor signaling pathway - Homo sapiens (human)
- Nucleotide-binding Oligomerization Domain (NOD) pathway
- TP53 Regulates Transcription of Cell Death Genes
Biological Process
- activation of innate immune response
- apoptotic process
- activation of cysteine-type endopeptidase activity involved in apoptotic process
- inflammatory response
- detection of bacterium
Molecular Function
- magnesium ion binding
- protein binding
- ATP binding
- identical protein binding
- protein homodimerization activity
Cellular Component
- cytosol
- IPAF inflammasome complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000404025
- Coding exons
- 8
- Length
- 41402
- Individuals with no LoFs
- 125526
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 221
- Defined
- 125748
- p
- 0.000883
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.977 | 476 | 540 | 0.882 | 0.0000276 | 6828 |
| Missense (PolyPhen) | 98 | 134.13 | 0.73064 | 1904 | ||
| Synonymous | -0.0576 | 213 | 212 | 1.00 | 0.0000113 | 1948 |
| Loss of Function | 1.94 | 23 | 35.5 | 0.648 | 0.00000185 | 454 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0015 | 0.0015 | notable |
| Latino/Admixed American | 0.00084 | 0.00084 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.0016 | 0.0016 | notable |
| Finnish | 0.0012 | 0.0012 | notable |
| European (Non-Finnish) | 0.00089 | 0.00089 | rare |
| South Asian | 0.00040 | 0.00039 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Key component of inflammasomes that indirectly senses specific proteins from pathogenic bacteria and fungi and responds by assembling an inflammasome complex that promotes caspase-1 activation, cytokine production and macrophage pyroptosis (PubMed:15107016). The NLRC4 inflammasome is activated as part of the innate immune response to a range of intracellular bacteria (By similarity). {ECO:0000250|UniProtKB:Q3UP24, ECO:0000269|PubMed:15107016}.;
- Disease
- DISEASE: Autoinflammation with infantile enterocolitis (AIFEC) [MIM:616050]: An autosomal dominant disorder characterized by neonatal-onset enterocolitis, periodic fever, and fatal or near- fatal episodes of autoinflammation. Affected individuals tend to have poor overall growth and gastrointestinal symptoms in infancy, recurrent febrile episodes with splenomegaly, and sometimes hematologic disturbances, arthralgias, or myalgias. {ECO:0000269|PubMed:25217959, ECO:0000269|PubMed:25217960}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Familial cold autoinflammatory syndrome 4 (FCAS4) [MIM:616115]: A form of autoinflammatory syndrome, a rare autosomal dominant systemic disease characterized by recurrent episodes of maculopapular rash associated with arthralgias, myalgias, fever and chills, swelling of the extremities, and conjunctivitis after generalized exposure to cold. {ECO:0000269|PubMed:25385754}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.321
Intolerance Scores
- LoFtool
- 0.850
- RVIS EVS
- -0.6
- RVIS percentile EVS
- 18.21
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.523
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |